FDA Inspection
Carl P. Griffin, M.D.Carl P. Griffin, M.D. – FDA Inspection, Nov 17, 2023
Record Details
This FDA Inspection record concerns Carl P. Griffin, M.D., with an inspection on November 17, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 725d056c-c599-4872-a646-fa9dd38f7672
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224307
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Carl P. Griffin, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2021 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| February 1, 2019 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| July 12, 2010 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 24, 2008 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Carl P. Griffin, M.D.
- FDA Inspection 1149497 - 2021-08-05
- FDA Inspection 1079217 - 2019-02-01
- FDA Inspection 674866 - 2010-07-12
- FDA Inspection 550865 - 2008-10-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.